Lennham has a total of 47 patents globally, out of which 10 have been granted. Of these 47 patents, more than 80% patents are active. United States of America is where Lennham has filed the maximum number of patents, followed by Europe and Taiwan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Lennham.
Lennham was founded in the year 2019. The Company helps to improve the metabolic and pharmacological profiles of drugs through deuterium chemistry.
Do read about some of the most popular patents of Lennham which have been covered by us in this article and also you can find Lennham patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Lennham patent portfolio.
How many patents does the founder and the CEO of Lennham have?
The founder and CEO Bradford Sippy has 5 patents.
How many patents does Lennham have?
Lennham has a total of 47 patents globally. These patents belong to 10 unique patent families. Out of 47 patents, 38 patents are active.
How Many Patents did Lennham File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Lennham Applications Filed | Lennham Patents Granted |
| 2023 | – | 3 |
| 2022 | 11 | 3 |
| 2021 | 15 | 2 |
| 2020 | 20 | 2 |
| 2019 | 1 | – |
How many Lennham patents are Alive/Dead?
How Many Patents did Lennham File in Different Countries?
Countries in which Lennham Filed Patents
| Country | Patents |
| United States Of America | 17 |
| Europe | 3 |
| Taiwan | 3 |
| New Zealand | 1 |
| Korea (South) | 1 |
| China | 1 |
| Hong Kong (S.A.R.) | 1 |
| Mexico | 1 |
| Israel | 1 |
| Russia | 1 |
| Singapore | 1 |
| Canada | 1 |
| Brazil | 1 |
| South Africa | 1 |
| India | 1 |
| Australia | 1 |
| Japan | 1 |
Where are Research Centres of Lennham Patents Located?
The Research Centre for all the Lennham patents is the United States of America.
10 Best Lennham Patents
US11000534B1 is the most popular patent in the Lennham portfolio. It has received 26 citations so far from companies like Small Pharma Ltd, Terran Biosciences and Enveric Biosciences Canada.
Below is the list of 10 most cited patents of Lennham:
| Publication Number | Citation Count |
| US11000534B1 | 26 |
| US20220110955A1 | 5 |
| US10582716B1 | 4 |
| US11324762B2 | 3 |
| US20200390128A1 | 3 |
| US10765130B1 | 2 |
| US20210378266A9 | 2 |
| US11202785B1 | 1 |
| WO2022076642A1 | 1 |
| WO2020252302A1 | 1 |
What Percentage of Lennham US Patent Applications were Granted?
Lennham (Excluding its subsidiaries) has filed 12 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 80.0%.
Below are the key stats of Lennham patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Lennham?
| Law Firm | Total Applications | Success Rate |
| Lennham Pharmaceuticals | 8 | 71.43% |
| Foley Hoag Llp General | 4 | 100.00% |
List of Lennham Patents
| Lennham Patents | Title |
| US11666073B2 | Deuterated Caffeine And Uses Thereof |
| US11633371B2 | Deuterated Forms Of Acetaminophen And Uses Thereof |
| US11547127B2 | Deuterated Caffeine And Uses Thereof |
| US11471469B2 | Deuterated Forms Of Testosterone And Methods Of Use |
| US11344564B1 | Method Of Treatment Based On Reduced Monoamine Oxidase A Activity |
| US11324762B2 | Deuterated Derivatives Of Psilocybin And Uses Thereof |
| US11202785B1 | Deuterated Forms Of Testosterone And Methods Of Use |
| US11000534B1 | Deuterated Derivatives Of Psilocybin And Uses Thereof |
| US10765130B1 | Deuterated Caffeine And Uses Thereof |
| US10582716B1 | Deuterated Caffeine And Uses Thereof |
| US20230124138A1 | Deuterated Forms Of Testosterone And Methods Of Use |
| US20230062523A1 | Method Of Treatment Based On Reduced Monoamine Oxidase A Activity |
| US20220313630A1 | Deuterated Forms Of Acetaminophen And Uses Thereof |
| US20220288083A1 | D9 Caffeine Compositions And Uses Thereof |
| US20220110955A1 | Deuterated Derivatives Of Psilocybin And Uses Thereof |
| EP4255439A1 | Deuterated Forms Of Testosterone And Methods Of Use |
| EP3979999A4 | Deuterated Forms Of Acetaminophen And Uses Thereof |
| EP3982759A4 | Deuterated Caffeine And Uses Thereof |
| CN114007622A | Deuterated Caffeine And Uses Thereof |
| WO2023043899A1 | Deuterated Derivatives Of Salvinorin A And Uses Thereof |
| WO2023023155A1 | Method Of Treatment Based On Reduced Monoamine Oxidase A Activity |
| WO2022225884A1 | Deuterated Derivatives Of Psychedelic Compounds And Uses Thereof |
| CA3138347A1 | Deuterated Caffeine And Uses Thereof |
| HK40067705A | Deuterated Caffeine And Uses Thereof |
| MX2021015509A | Deuterated Caffeine And Uses Thereof. |
| AU2020292375A1 | Deuterated Caffeine And Uses Thereof |
| IL288944A | Deuterated Caffeine And Uses Thereof |
| JP2022536928A5 | Deuterated Caffeine And Uses Thereof |
| RU2021139137A | Deuterated Caffeine And Its Applications |
| TW202237139A | Deuterated Forms Of Testosterone And Methods Of Use |
| TW202228716A | Deuterated Derivatives Of Psilocybin And Uses Thereof |
| TW202227085A | Deuterated Paraxanthine And Uses Thereof |
| IN202217001705A | Deuterated Caffeine And Uses Thereof |
| KR1020220020898A | Deuterated Caffeine And Uses Thereof |
| BR112021023614A2 | Deuterated Caffeine And Its Uses |
| SG11202112395SA | Deuterated Caffeine And Uses Thereof |
| ZA202108446A | Deuterated Caffeine And Uses Thereof |
| NZ781723A | Deuterated Caffeine And Uses Thereof |
| US20210378266A9 | Deuterated Caffeine And Uses Thereof |
| US20200390128A1 | Deuterated Caffeine And Uses Thereof |
| WO2022192271A1 | D9 Caffeine Compositions And Uses Thereof |
| WO2022159813A1 | Products Comprising Deuterium Enriched Water |
| WO2022120054A1 | Deuterated Forms Of Testosterone And Methods Of Use |
| WO2022056190A3 | Deuterated Paraxanthine And Uses Thereof |
| WO2022076642A1 | Deuterated Derivatives Of Psilocybin And Uses Thereof |
| WO2020252302A1 | Deuterated Caffeine And Uses Thereof |
| WO2020247458A1 | Deuterated Forms Of Acetaminophen And Uses Thereof |
What are Lennham key innovation segments?
What Technologies are Covered by Lennham?
The chart below distributes patents filed by Lennham